Methamphetamine-associated psychosis: A new health challenge in Iran

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Alam Mehrjerdi, Zahra ^a   Barr, Alasdair M ^b   Noroozi, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; METHAMPHETAMINE;

AUDITORY HALLUCINATION; AUTOMUTILATION; DELUSION; DISORIENTATION; DRUG USE; ELECTROCONVULSIVE THERAPY; EMERGENCY MEDICINE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; IRAN; MENTAL HEALTH SERVICE; MENTAL INSTABILITY; OUTPATIENT DEPARTMENT; PERSECUTORY DELUSION; PRESCRIPTION; PSYCHOSIS; REVIEW; VISUAL HALLUCINATION;

EID: 84876940127     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-30     Document Type: Review

References (28)

1. Methamphetamine abuse a new concern in Iran. Mehrpour O, Daru 2012 20 73 PMID:23351837 10.1186/2008-2231-20-73 23351837
2. The need for speed: An update on methamphetamine addiction. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T, J Psychiatr Neurosci 2006 31 301 313 PMID: 16951733, PMCID: PMC1557685 (Pubitemid 44497427)
3. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic super sensitivity-a clinical survey. Sato M, Psychopharmacol Bull 1986 22 751 756 3797580 (Pubitemid 17183377)
4. Stimulant psychosis: symptom profile and acute clinical course. Harris D, Batki SL, Am J Addict 2000 9 28 37 10.1080/10550490050172209 10914291 (Pubitemid 30155031)
5. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ujike H, Sato M, Ann NY Acad Sci 2004 1025 279 287 10.1196/annals.1316.035 15542728 (Pubitemid 39643873)
6. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Matsumoto T, Karmijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, Okudaira K, Iseki E, Sakai T, Kosaka K, Addiction 2002 97 809 817 10.1046/j.1360-0443.2002.00143.x 12133119 (Pubitemid 34729095)
7. The prevalence of psychotic symptoms among methamphetamine users. McKetin R, McLaren J, Lubman DI, Hides L, Addiction 2006 101 1473 1478 10.1111/j.1360-0443.2006.01496.x 16968349 (Pubitemid 44337772)
8. Psychotic symptoms in methamphetamine psychotic in-patients. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M, I J Neuropsychopharmacol 2003 6 347 352 10.1017/S1461145703003675 (Pubitemid 38146252)
9. Chronic schizophrenia-like states in methamphetamine psychosis. Tomiyama G, Jpn J Psychiatry Neurol 1990 44 531 539 2074612
10. Noradrenergic activity and spontaneous recurrence of methamphetamine psychosis. Yui K, Goto K, Ishiguro T, Ikemoto S, Drug Alcohol Depend 1997 44 183 187 10.1016/S0376-8716(97)01336-7 9088791 (Pubitemid 27129512)
11. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, the Methamphetamine treatment project corporate authors, J Sub Abuse Treat 2008 35 445 450 10.1016/j.jsat.2007.12.004
12. United Nations Office on Drugs and Crime, World Drug Report Vienna, Austria 2012 Retrieved from http://www.unodc.org/documents/data/WDR2012/WDR- 2012-WRD-Small
13. An emerging trend of methamphetamine injection in Iran: A critical target for research on blood-borne infection diseases. Alam mehrjerdi Z, Noroozi AR, Hepat Mon 2013 2 1 3 Retrieved from hepatmon.com/?page=download&file-id= 15040
14. Drug Control in 2008, Annual report and rapid situation assessment Tehran, Iran: Islamic Republic of Iran, Drug Control Headquarters 2009 https://www.paris-pact.net/upload/60917b46799714c5bfe0b0b2dc6f9e82.pdf
15. Symptoms and course of psychotic symptoms in methamphetamine induced psychosis: A case series. Shariat SV, Elahi A, Ahmadzad Asl M, Tehran, Iran: Ninth annual meeting of the Iranian psychiatric association 2009 Retrieved from http://www.ncbi.nlm.nih.gov. v.12 (5); 2010
16. Symptoms and course of psychosis after methamphetamine abuse: one-year follow-up of a case. Shariat SV, Elahi A, Prim Care Companion J Clin Psychiatry 2010 12 5 Retrieved from http://www.ncbi.nlm.nih.gov. v.12 (5); 2010
17. Amphetamine psychosis and eye autoenucleation. Omidvar T, Sharifi V, Aust N Z J Psychiatry 2012 46 71 10.1177/0004867411427810 22247101
18. Delusional problems and mood instability in acute psychiatric patients dependent to methamphetamine named Shishe among Iranian population. Saberi SM, Khodabandeh F, Khani A, Marashi SM, J Addict Res Ther 2012 3 4 Retrieved from 10.4172/2155-6105.1000132
19. Clinical features of inpatients with methamphetamine-induced psychosis. Fashipour B, Molavi S, Shariat SV, J Ment Health 2013 22 1 9 10.3109/09638237.2012.760192 23343043
20. Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Zarghami M, Iran J Psychiatr Behav Sci 2011 5 1 5 Retrieved from http://ijpbs.mazums.ac.ir/browse.php? a-code=A-10-2-39&slc- lang=en& sid=1
21. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Batki SL, Harris DS, Am J Addict 2004 13 461 470 10.1080/10550490490512834 15764424 (Pubitemid 39603291)
22. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. RANZCP, Aust N Z J Psychiatry 2005 39 1 30 PMID: 15660702 15660702
23. Olanzapine treatment of methamphetamine psychosis. Misra LK, Kofoed L, Oesterheld JR, Richards GA, J Clin Psychopharmacol 2000 20 393 394 10.1097/00004714-200006000-00023 10831035 (Pubitemid 30318377)
24. Risperidone treatment of methamphetamine psychosis. Misra L, Kofoed L, Am J Psychiatry 1997 154 1170 9247414
25. Drug-induced psychosis associated with crystalline methamphetamine. Dore G, Sweeting M, Australas Psychiatry 2006 14 86 89 16630206
26. Stimulant psychosis: Systematic review. Curran C, Byrappa N, McBride A, Br J Psychiatr 2004 185 196 204 10.1192/bjp.185.3.196 (Pubitemid 39208220)
27. Psychiatric symptoms in methamphetamine users. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M, Am J Addict 2004 13 181 190 10.1080/10550490490436055 15204668 (Pubitemid 38585698)
28. Lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Sato MA, Ann N Y Acad Sci 1992 654 160 170 10.1111/j.1749-6632.1992.tb25965.x 1632581